112th Congress · Public law
Public Law 112-144
An act to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
July 9, 2012date on the GovInfo record
126 Stat. 993Statutes at Large
9roll calls on its bill in our archive
The official record
Official copies of this law
Source: GovInfo, U.S. Government Publishing Office — Public and Private Laws and United States Statutes at Large.
Where it came from
The bill
GovInfo's record for this law names S. 3187 of the 112th Congress as its bill (record ↗).
How it passed
Recorded votes on the bill
Senate Vote 105 (112th Congress, 2nd Session) · May 24, 2012
On the Amendment — Amendment Rejected (28–67)
Senate Vote 106 (112th Congress, 2nd Session) · May 24, 2012
On the Amendment — Amendment Rejected (46–50)
Senate Vote 107 (112th Congress, 2nd Session) · May 24, 2012
On the Motion to Table — Motion to Table Agreed to (78–15)
Senate Vote 108 (112th Congress, 2nd Session) · May 24, 2012
On the Amendment — Amendment Rejected (43–54)
Senate Vote 109 (112th Congress, 2nd Session) · May 24, 2012
On the Amendment — Amendment Rejected (9–88)
Senate Vote 110 (112th Congress, 2nd Session) · May 24, 2012
On the Motion to Table — Motion to Table Agreed to (77–20)
Senate Vote 111 (112th Congress, 2nd Session) · May 24, 2012
On Passage of the Bill — Bill Passed (96–1)
Senate Vote 166 (112th Congress, 2nd Session) · June 25, 2012
On the Cloture Motion — Cloture Motion Agreed to (89–3)
Senate Vote 168 (112th Congress, 2nd Session) · June 26, 2012
On the Motion — Motion Agreed to (92–4)
Roll calls matched by the bill number GovInfo names; each vote page links to its official chamber record.